Chimeric Antigen Receptor T-Cell Therapy: Are Neuroradiologists Prepared?

References

1. 1.↵
   2. Valand HA,
   3. Huda F,
   4. Tu RK

   . Chimeric antigen receptor t-cell therapy: what the neuroradiologist needs to know. AJNR Am J Neuroradiol 2019;40:766–68 doi:10.3174/ajnr.A6042 pmid:31048298

   Abstract/FREE Full Text
2. 2.↵
   2. Santomasso BD,
   3. Park JH,
   4. Salloum D, et al

   . Clinical and biological correlates of neurotoxicity associated with CAR t-cell therapy in patients with b-cell acute lymphoblastic leukemia. Cancer Discov 2018;8:958–71 doi:10.1158/2159-8290.CD-17-1319 pmid:29880584

   Abstract/FREE Full Text
3. 3.↵
   2. Gust J,
   3. Finney OC,
   4. Li D, et al

   . Glial injury in neurotoxicity after pediatric cd19-directed chimeric antigen receptor t cell therapy. Ann Neurol 2019;86:42–54 doi:10.1002/ana.25502 pmid:31074527

   CrossRefPubMed